Innovation for Health - 14 February 2019
Global Investor Forum Contact
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare

Hanneke Schuitemaker

Global Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines

Session

14:15 - 15:25
From treatment to prevention

Hanneke Schuitemaker is the Global Head of Viral Vaccine Discovery and Translational Medicine in the Infectious Disease and Vaccines Therapeutic Area of Janssen Vaccines and a professor in virology at the Academic Medical Center of the University of Amsterdam.
She is a medical biologist by training, received her PhD in Medicine in 1992 at the University of Amsterdam and worked for more than 20 years on HIV-1 pathogenesis.
In her current position, she is responsible for the port-folio of viral vaccine programs that are in the phase of discovery or early development. Most advanced programs in that port-folio are vaccine candidates for HIV, Ebola, Zika, RSV.

Abstract

Challenges of future pandemics and infectious diseases
In our hyper-connected world, we are facing the escalating threat of epidemics from infectious diseases. Each year, infectious diseases account for 16% of deaths worldwide, and it is widely understood that infectious diseases will spread more and more easily in the future due to globalization, population growth and aging, antimicrobial resistance, increasing travel, the development of megacities and climate change.
Janssen is dedicated to advancing human health by developing potentially transformational vaccines to prevent and intercept some of these life-threatening diseases, such as HIV, Influenza and Ebola, which offer pandemic threat.
End of 2017, the company initiated a Phase 2b proof-of-concept study (HPX2008/HVTN 705 – also known as “Imbokodo”) with partners to evaluate a mosaic-based preventive HIV-1 vaccine. The study will assess whether the vaccine regimen is effective in reducing the incidence of HIV infection among 2,600 women in sub-Saharan Africa.
Janssen is also committed to develop a vaccine to help prevent the spread of Ebola. Ongoing outbreaks demonstrate the importance of disease surveillance and management, the value of strong health systems, and the need to finish the job of developing safe and effective vaccines to help protect communities and prevent a resurgence of the virus.
During “Challenges of future pandemics and infectious diseases” Hanneke Schuitemaker, Vice President, Global Head of Viral Vaccine Discovery and Translational Medicine will discuss the challenges of future infectious diseases pandemics and the potential vaccines could provide to avoid future outbreaks.

Henk van Houten
Royal Philips

Henk van Houten
Edwin Moses
Ablynx
Edwin Moses

Peter Paul van Benthem
Dutch Association of Medical Specialists

Peter Paul van Benthem
Niels Chavannes
LUMC
Niels Chavannes

Madelon Maurice
UMC Utrecht & Oncode Institute

Madelon Maurice
Ingmar de Gooijer
myTomorrows
Ingmar de Gooijer
Tom Miller
GreyBird Ventures
Tom Miller
Mark van Houdenhoven
Sint Maartenskliniek
Mark van Houdenhoven
Ruben Kok
Dutch Techcentre for Life Sciences
Ruben Kok
Colja Laane
Mibiton
Colja Laane

Arthur Lahr
Kiadis Pharma

Arthur Lahr
Eveliene Manten-Horst
AYA Jongvolwassen & Kanker
Eveliene Manten-Horst
Kas Maessen
NWO Grootschalig Infrastructuur
Kas Maessen
Eline Vrijland-van Beest
NightBalance
Eline Vrijland-van Beest
Jos Malda
UMC Utrecht
Jos Malda
Lucien Hordijk
Journalist
Maarten van Dongen
LabForRent
Maarten van Dongen
Kees Recourt
Mibiton Foundation
Kees Recourt

Maurits van Selms
ACTA

Maurits Selms
Marianne van der Steen
MERLN
Marianne van der Steen
Werner Verbiest
Janssen Diagnostics
Werner Verbiest
Markwin Velders
Kite Pharma
Markwin Velders
Nicolas Vergauwe
miDiagnostics
Nicolas Vergauwe

Marc Schellekens
LabHotel Rotterdam

Marc Schellekens
Bert-Arjan Millenaar
NLC The Healthtec Venture Builder
Bert-Arjan Millenaar
Phil L'Huillier
MSD
Jeff Gielen
Kadans Science Partner
Jeff Gielen
Annemiek Verkamman
HollandBIO
Ton van der Steen
Erasmus MC Medical Delta
Hans Schikan
Health~Holland
Joep de Groot
CbusineZ
Joep de Groot
Peter Hinssen
nexxworks
Sponsors & Partners
Main partner
Health~Holland
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Sponsor
Kempen
Partner
Vereniging Innovatieve Geneesmiddelen
Partner
Global Investor Forum
Your logo?
Become a sponsor of Innovation for Health 2019!
© 2018 Innovation for Health